Wan Meihui, chief engineer of Zhongrui Funing, introduced that the Ophthorobotics ophthalmic surgery robot (hereinafter referred to as the OR ophthalmic robot) can use 1 second to complete the amD (age-related fundus macular degeneration) and other fundus diseases caused by the increase in VEGF concentration for injection treatment in 1 second. Not only will it drastically reduce the time and cost of surgery, but it will also improve patient comfort, which will revolutionize this segment of medical field.
"THE TECHNICAL LEVEL OF OR IS VERY HIGH, FROM THE SUCCESS RATE OF SURGERY, TO THE OPTIMIZATION OF SURGICAL PROCESSES AND THE PATIENT EXPERIENCE. OUR PRODUCTS HAVE BEEN CLINICALLY TESTED IN SWITZERLAND. OR IS A MILESTONE IN THE MEDICAL ROBOTICS INDUSTRY IN CHINA AND EVEN IN THE WORLD," SAID WAN MEIHUI.
zhongrui funing company, established in december 2016 in shenyang, is an international industrial group that mainly designs, develops and applies intelligent service robots, and integrates scientific research and production with industrial ecological innovation and capital operation. the main business includes the development and industrial incubation of medical health, old-age assistance and disability assistance and special robots.
according to the ophthalmology society of the chinese medical association, there are about 40,000 qualified ophthalmologists in china, which is close to the number of ophthalmologists in the united states. considering that the united states only has one-fifth of the chinese population, china is still short of 150,000 ophthalmologists if it meets american standards. according to china's national health commission, more than 70 percent of doctors are stressed at work.
the shortage of high-quality medical services is precisely the market opportunity for medical robots. according to the boston consulting group, the global medical robot scale is expected to reach $11.4 billion in 2020, becoming the second largest robot market. among them, surgical robots account for about 60% of the market share.
Public information shows that the United States, the European Union and Japan attach great importance to medical robots, and list robotics for Healthcare as the second most important development direction in the field of robotics, second only to industrial robots. China has also clearly proposed to develop "high-performance diagnostic and treatment equipment such as medical robots".
in april 2016, the ministry of industry and information technology, the national development and reform commission and the ministry of finance jointly issued the "robot industry development plan (2016-2020)", proposing that by 2020, the annual sales revenue of china's service robots will exceed 30 billion yuan, and small-batch production and application will be realized in the fields of helping the elderly and the disabled, medical rehabilitation and other fields.
yu qingming, chairman of china medical device co., ltd., said that promoting the localization of medical devices and realizing import substitution has always been the direction of the entire industry.
ophthalmic surgical robots are extremely technically demanding, because the eye is one of the most important organs of the body, and the nerves of the eye are the densest parts of the body. in order to achieve the international first-class level, funing set up an international r & d team at the beginning of its establishment, the company has 125 r & d personnel in europe. and with sweden, switzerland, germany and other high-end robot research and development institutions to establish cooperative relations.
The CTO of the OR Robotics Project is Professor Bradley J. Nelson of the Swiss Federal Institute of Technology. He introduced that OR uses a special iris recognition and eye tracking system, which can accurately identify the lesion part and accurately locate the best injection site. Injections and drug delivery are then carried out automatically in vitreous in 1 second.
"the whole operation was completed in the blink of an eye, and the patient didn't even feel that an eye injection had been done. this is completely different from traditional surgery, which requires anesthesia on the patient first, and then takes more than 1 hour to do the operation. ”
while actively transforming international cutting-edge technology, funing adheres to independent research and development to create service robot products with funing's patents that truly meet the needs of the chinese market. the company has applied for 52 patents, including 23 international patents.
industry experts suggest that in the emerging industry of medical robots, china, the united states and europe are currently in the "infancy period", and the government can increase support for research and development to achieve overtaking in china's health industry.
"the development of the robot industry is an exploration of how technology, intelligence and human beings can coexist in harmony in the future. from its inception to the present, we have always adhered to global collaborative innovation, open cooperation and win-win results. connect smart medical care services with science and technology, and contribute to the construction of a community with a shared future for mankind. ”
